Hand Sanitiser Manufacturing — Standard Project Report
Hand Sanitiser Manufacturing in India — what the report covers
Hand sanitiser is a cold-mix product — alcohol, a gelling agent, humectant, water and fragrance. The manufacturing is simple; the barriers are regulatory and input-cost. Sanitiser is licensed as a drug in India, the alcohol attracts excise and flammable-liquid controls, and post-2020 the market has settled to a much smaller, over-supplied, thin-margin category dominated by ethanol cost. On the report’s own numbers it is not a strong stand-alone small-business bet in 2026 — it works best as an add-on line, a contract-manufacturing play, or one format in a wider hygiene range.
Market at a glance
India’s hand-sanitiser market was USD 138–151 million in 2024 (IMARC Group / ResearchAndMarkets), forecast to about USD 203 million by 2030 at a ~5.1% CAGR (ResearchAndMarkets). The market contracted sharply from the 2020–21 peak and has stabilised at a base still above pre-2020, led by healthcare and institutional use; pandemic-era capacity left the industry over-supplied, which with high ethanol cost keeps commodity-end margins thin.
Manufacturing process
A single-vessel cold-mix process in a classified (flammable-atmosphere) area — alcohol and water charging, gelling-agent and humectant blending, finishing, then filling.
Key statutory point
A Drugs & Cosmetics Rules manufacturing licence is mandatory — the product cannot be made or sold without it — and it forces qualified technical/QC staff and a compliant premises. Add state excise for the ethanol, a PESO flammable-liquid storage licence, and a Fire NOC.
3 independently costed setups
| Configuration | Total funds | Capacity | Operating model |
|---|---|---|---|
| Minimum Licensed Unit | ₹22.2 lakh | 1,00,000 L/yr | Smallest licensed premises, bulk / contract supply |
| Standard Licensed Small-Scale Unitanchor | ₹78.4 lakh | 3,00,000 L/yr | Semi-automatic, licensed rented unit, healthcare + institutional + contract |
| Expanded Multi-Format Unit | ₹2.92 crore | 9,00,000 L/yr | Automated, owned plant, gel + liquid + spray + foam range |
Total funds required = cost of project + working capital, on a 100%-own-funds basis. Each configuration is costed bottom-up from a researched equipment list, premises basis and manpower roster — not scaled from one another. The report is funding-neutral: it makes no assumption about how the promoter raises the capital.
Anchor configuration — 5-year financial model
Projected / indicative figures on the GF Standard Basis (cost basis August 2026, Tier-2 Indian industrial location, straight-line depreciation, 25% tax, no financing layer). Verify independently before committing funds.
Applicable public standards referenced: Drugs & Cosmetics Rules (manufacturing licence) · IS 17423 / WHO-formulation references for alcohol-based hand rubs · PESO flammable-liquid storage rules · State excise rules (denatured spirit).
Every section, in order
- Product description, applications and end-use segments
- Market analysis with cited third-party sources
- Manufacturing process at unit-operation level, with a process-flow diagram
- 1–3 independently costed investment configurations (low-investment → standard → expanded)
- Plant & machinery lists with indicative August-2026 costs
- Raw materials by functional class, with cost split and availability
- Infrastructure, utilities and manpower
- Full statutory & environmental compliance roadmap (Udyam, GST, Factory licence, PCB, Fire NOC, BIS, product-specific licences)
- 5-year financial model for the anchor configuration — cost of project, working capital, projected P&L, break-even, IRR / NPV / payback
- Low-investment trade-off disclosure with a viability verdict
- SWOT analysis
- Annexures — standards & references, sector bodies & testing labs, glossary
What this report does not include
- Manufacturing formulations, recipes or batch sheets
- Raw-material specifications, grades or brand names
- Supplier or vendor lists
- Technical, engineering or QC consulting
This is a business feasibility study, not a technical manual. For production-ready formulations, raw-material profiles and QC targets, see the matching Formulations Handbook.
Built for the person doing the planning
First-time entrepreneurs
A realistic, bottom-up view of what it costs to start — and the lowest-investment setup that still works and is legal.
Existing manufacturers
Adding a new product line and needing to size the capex, working capital and returns before committing.
Proposal preparation
A structured, sourced starting point for a project proposal or an internal investment case.
Consultants & students
A worked example of an MSME feasibility study for a formulated-chemical product.
Frequently asked questions
Is hand sanitiser still a good business to start in 2026?
The report is candid that it is not a strong stand-alone small-business bet on current numbers — the anchor shows a ~15% project IRR and a ~5.9-year payback, held down by the drug-licence compliance load and thin ethanol-dominated margins in an over-supplied market. It works best as an add-on line for an existing cleaner / cosmetic / pharma unit, a contract-manufacturing play, or one format in a wider hygiene range.
What licence is needed to manufacture hand sanitiser in India?
A Drugs & Cosmetics Rules manufacturing licence — sanitiser is regulated as a drug and cannot be made or sold without it. The licence forces qualified technical and QC staff and a compliant premises. On top of that: state excise for the ethanol, a PESO flammable-liquid storage licence, and a Fire NOC.
How much does a hand sanitiser plant cost?
Three configurations: a minimum licensed unit at about ₹22.2 lakh total funds (1,00,000 L/yr), a standard licensed small-scale unit at about ₹78.4 lakh (3,00,000 L/yr — the anchor), and an automated multi-format plant at about ₹2.92 crore (9,00,000 L/yr).
Why does ethanol cost matter so much?
Alcohol is 70–80% of product volume, so its price — and its excise treatment — drives the margin. The report notes a small ethanol move swings profitability, and denatured ₹70–95/L is the modelled input band. This is the single biggest economic sensitivity in the report.
Will this report give me the formulation?
No. Standard Project Reports are feasibility and financial studies only. Raw materials are described by functional class (e.g. "anionic surfactant"), never by grade, trade name or supplier. For production-ready formulations, see the matching Global Formulation handbook.
How are the investment figures arrived at?
Each configuration is costed bottom-up from researched equipment, premises and manpower — not scaled from a single template. The report presents the total funds required (cost of project + working capital) on a 100%-own-funds basis; it does not assume or advise on how you raise the capital.
What format is it and how do I get it?
A PDF, delivered by instant download link the moment payment is confirmed, and kept in your library. Up to 5 downloads are included.
How current are the costs?
The cost basis is August 2026, benchmarked to a Tier-2 Indian industrial location against public marketplace listings and MSME project profiles. All figures are indicative and must be verified with vendors and professionals before you commit funds.
This report is a detailed answer to searches such as: hand sanitiser manufacturing plant cost · hand sanitizer making business project report · sanitiser drug licence India · hand sanitiser manufacturing process · is hand sanitiser business profitable 2026.
